1. Home
  2. REKR vs INO Comparison

REKR vs INO Comparison

Compare REKR & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

HOLD

Current Price

$0.71

Market Cap

96.5M

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.14

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REKR
INO
Founded
2017
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.5M
90.5M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
REKR
INO
Price
$0.71
$1.14
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
2.0M
1.6M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
4.35
54.18
EPS
N/A
N/A
Revenue
$9,234,000.00
$42,220,086.00
Revenue This Year
$12.51
$20,156.19
Revenue Next Year
$23.49
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$0.67
$1.03
52 Week High
$3.42
$2.86

Technical Indicators

Market Signals
Indicator
REKR
INO
Relative Strength Index (RSI) 43.51 43.12
Support Level $0.70 $1.03
Resistance Level $0.92 $1.23
Average True Range (ATR) 0.04 0.06
MACD -0.00 -0.00
Stochastic Oscillator 18.78 27.08

Price Performance

Historical Comparison
REKR
INO

About REKR Rekor Systems Inc.

Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: